These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 26792250)

  • 1. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
    Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
    JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
    Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
    JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of Multiple Skin Cancers in Organ Transplant Recipients: A Cohort Study in 2 Administrative Data Sets.
    Wehner MR; Niu J; Wheless L; Baker LX; Cohen OG; Margolis DJ; Giordano SH; Shin TM
    JAMA Dermatol; 2021 Dec; 157(12):1447-1455. PubMed ID: 34668933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States.
    Garrett GL; Blanc PD; Boscardin J; Lloyd AA; Ahmed RL; Anthony T; Bibee K; Breithaupt A; Cannon J; Chen A; Cheng JY; Chiesa-Fuxench Z; Colegio OR; Curiel-Lewandrowski C; Del Guzzo CA; Disse M; Dowd M; Eilers R; Ortiz AE; Morris C; Golden SK; Graves MS; Griffin JR; Hopkins RS; Huang CC; Bae GH; Jambusaria A; Jennings TA; Jiang SI; Karia PS; Khetarpal S; Kim C; Klintmalm G; Konicke K; Koyfman SA; Lam C; Lee P; Leitenberger JJ; Loh T; Lowenstein S; Madankumar R; Moreau JF; Nijhawan RI; Ochoa S; Olasz EB; Otchere E; Otley C; Oulton J; Patel PH; Patel VA; Prabhu AV; Pugliano-Mauro M; Schmults CD; Schram S; Shih AF; Shin T; Soon S; Soriano T; Srivastava D; Stein JA; Sternhell-Blackwell K; Taylor S; Vidimos A; Wu P; Zajdel N; Zelac D; Arron ST
    JAMA Dermatol; 2017 Mar; 153(3):296-303. PubMed ID: 28097368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
    De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
    JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Posttransplant Dermatologic Diseases by Race.
    Chung CL; Nadhan KS; Shaver CM; Ogrich LM; Abdelmalek M; Cusack CA; Malat GE; Pritchett EN; Doyle A
    JAMA Dermatol; 2017 Jun; 153(6):552-558. PubMed ID: 28273280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study.
    Rizvi SMH; Aagnes B; Holdaas H; Gude E; Boberg KM; Bjørtuft Ø; Helsing P; Leivestad T; Møller B; Gjersvik P
    JAMA Dermatol; 2017 Dec; 153(12):1270-1277. PubMed ID: 29049612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Types of Genital Lesions in Organ Transplant Recipients.
    Nadhan KS; Larijani M; Abbott J; Doyle AM; Linfante AW; Chung CL
    JAMA Dermatol; 2018 Mar; 154(3):323-329. PubMed ID: 29387873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk Prognostic Tumor Features of Squamous Cell Carcinomas in Organ Transplant Recipients Compared With the General Population.
    Pandeya N; Isbel N; Campbell S; Chambers DC; Hopkins P; Soyer HP; Jiyad Z; Plasmeijer EI; Whiteman DC; Olsen CM; Green AC
    JAMA Dermatol; 2023 Aug; 159(8):854-858. PubMed ID: 37314794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
    Tessari G; Naldi L; Boschiero L; Nacchia F; Fior F; Forni A; Rugiu C; Faggian G; Sassi F; Gotti E; Fiocchi R; Talamini G; Girolomoni G
    Arch Dermatol; 2010 Mar; 146(3):294-9. PubMed ID: 20231501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure.
    Terhorst D; Drecoll U; Stockfleth E; Ulrich C
    Br J Dermatol; 2009 Nov; 161 Suppl 3():85-9. PubMed ID: 19775362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients.
    Kang W; Sampaio MS; Huang E; Bunnapradist S
    Transplantation; 2017 Jun; 101(6):1303-1309. PubMed ID: 27336396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
    Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
    Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
    J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of sirolimus in the prevention of cutaneous squamous cell carcinoma in organ transplant recipients.
    Leblanc KG; Hughes MP; Sheehan DJ
    Dermatol Surg; 2011 Jun; 37(6):744-9. PubMed ID: 21605234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.
    Harwood CA; Leedham-Green M; Leigh IM; Proby CM
    Arch Dermatol; 2005 Apr; 141(4):456-64. PubMed ID: 15837863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Skin Cancer Rates by Transplanted Organ Type and Patient Age After Organ Transplant in White Patients.
    Wheless L; Anand N; Hanlon A; Chren MM
    JAMA Dermatol; 2022 Nov; 158(11):1287-1292. PubMed ID: 36169974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
    Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
    JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
    Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
    Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients.
    Murray SL; Daly FE; O'Kelly P; O'Leary E; Deady S; O'Neill JP; Dudley A; Rutledge NR; McCormick A; Houlihan DD; Williams Y; Morris PG; Ni Raghallaigh S; Moloney FJ; Sexton DJ; Conlon PJ
    Ren Fail; 2020 Nov; 42(1):607-612. PubMed ID: 32605413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.